Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation

(2015) Catriona Crossan et al.   HEALTH TECHNOLOGY ASSESSMENT

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C

(2014) Emmanuel A. Tsochatzis et al.   HEPATOLOGY

Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis

(2014) Guangqin Xiao et al.   HEPATOLOGY

Liver cirrhosis

(2014) Emmanuel A Tsochatzis et al.   LANCET

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

The Diversity and Management of Chronic Hepatitis B Virus Infections in the United Kingdom: A Wake-up Call

(2012) Richard S. Tedder et al.   CLINICAL INFECTIOUS DISEASES

Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update

(2011) Giacomo Germani et al.   SEMINARS IN LIVER DISEASE

Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses

(2010) Gloria Woo et al.   GASTROENTEROLOGY

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy

(2010) E.A. Tsochatzis et al.   JOURNAL OF HEPATOLOGY

Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

(2010) Helen Dakin et al.   VALUE IN HEALTH

Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI)

(2008) Garry R. Barton et al.   VALUE IN HEALTH